734 related articles for article (PubMed ID: 34338718)
21. Value contribution of cenobamate for the treatment of Focal-Onset Seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through reflective Multi-Criteria Decision Analysis (MCDA).
Falip M; López González FJ; Martín-Herranz I; Merino-Bohórquez V; Montoya J; Rey Gómez-Serranillos I; Rodriguez Uranga JJ; Ruiz E; Sancho-López A; Trillo Mata JL; Antoni Vallès J; Álvarez-Barón E; Sabaniego J; Subías-Labazuy S; Gil A
Epilepsy Behav; 2023 Aug; 145():109350. PubMed ID: 37480633
[TBL] [Abstract][Full Text] [Related]
22. A comparison of cenobamate with other newer antiseizure medications for adjunctive treatment of focal-onset seizures: A systematic review and network meta-analysis.
Mulheron S; Leahy TP; McStravick M; Doran R; Delanty N
Seizure; 2024 May; 118():80-90. PubMed ID: 38643679
[TBL] [Abstract][Full Text] [Related]
23. Levetiracetam and Suicidality: A Case Report and Literature Review.
Esang M; Santos MG; Ahmed S
Prim Care Companion CNS Disord; 2020 Jul; 22(4):. PubMed ID: 32731314
[TBL] [Abstract][Full Text] [Related]
24. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials.
Bridge JA; Iyengar S; Salary CB; Barbe RP; Birmaher B; Pincus HA; Ren L; Brent DA
JAMA; 2007 Apr; 297(15):1683-96. PubMed ID: 17440145
[TBL] [Abstract][Full Text] [Related]
25. Safety and tolerability of adjunctive brivaracetam in epilepsy: In-depth pooled analysis.
Brandt C; Klein P; Badalamenti V; Gasalla T; Whitesides J
Epilepsy Behav; 2020 Feb; 103(Pt A):106864. PubMed ID: 31937513
[TBL] [Abstract][Full Text] [Related]
26. Number needed to treat and associated cost analysis of cenobamate versus third-generation anti-seizure medications for the treatment of focal-onset seizures in patients with drug-resistant epilepsy in Spain.
Villanueva V; Serratosa JM; Toledo M; Ángel Calleja M; Navarro A; Sabaniego J; Pérez-Domper P; Álvarez-Barón E; Subías S; Gil A
Epilepsy Behav; 2023 Feb; 139():109054. PubMed ID: 36603345
[TBL] [Abstract][Full Text] [Related]
27. Suicide-related events in patients treated with antiepileptic drugs.
Arana A; Wentworth CE; Ayuso-Mateos JL; Arellano FM
N Engl J Med; 2010 Aug; 363(6):542-51. PubMed ID: 20818889
[TBL] [Abstract][Full Text] [Related]
28. Suicidality and epilepsy: A systematic review and meta-analysis.
Wang H; Zhang Y; Tan G; Chen D; Fu Y; Liu L
Front Psychiatry; 2023; 14():1097516. PubMed ID: 37065883
[TBL] [Abstract][Full Text] [Related]
29. Duloxetine: meta-analyses of suicidal behaviors and ideation in clinical trials for major depressive disorder.
Acharya N; Rosen AS; Polzer JP; D'Souza DN; Perahia DG; Cavazzoni PA; Baldessarini RJ
J Clin Psychopharmacol; 2006 Dec; 26(6):587-94. PubMed ID: 17110815
[TBL] [Abstract][Full Text] [Related]
30. Measures of suicidality in phase 3 clinical trials of levomilnacipran ER in adults with major depressive disorder.
Thase ME; Gommoll C; Chen C; Kramer K; Khan A; Durgam S
CNS Spectr; 2017 Dec; 22(6):475-483. PubMed ID: 28521846
[TBL] [Abstract][Full Text] [Related]
31. Impact of Antiseizure Medications on Appetite and Weight in Children.
Buraniqi E; Dabaja H; Wirrell EC
Paediatr Drugs; 2022 Jul; 24(4):335-363. PubMed ID: 35596110
[TBL] [Abstract][Full Text] [Related]
32. Neurocognitive Effects of Antiseizure Medications in Children and Adolescents with Epilepsy.
Besag FMC; Vasey MJ
Paediatr Drugs; 2021 May; 23(3):253-286. PubMed ID: 33956338
[TBL] [Abstract][Full Text] [Related]
33. Meta-analysis of suicidality in placebo-controlled clinical trials of adults taking bupropion.
Wightman DS; Foster VJ; Krishen A; Richard NE; Modell JG
Prim Care Companion J Clin Psychiatry; 2010; 12(5):. PubMed ID: 21274361
[TBL] [Abstract][Full Text] [Related]
34. Is antiepileptic-induced suicidality a data-based class effect or an exaggeration? A comment on the literature.
Siamouli M; Samara M; Fountoulakis KN
Harv Rev Psychiatry; 2014; 22(6):379-81. PubMed ID: 25377614
[TBL] [Abstract][Full Text] [Related]
35. A prospective, multicenter, noninterventional study in Taiwan to evaluate the safety and tolerability of lacosamide as adjunctive therapy for epilepsy in clinical practice.
Wu T; Chuang YC; Huang HC; Lim SN; Hsieh PF; Lee WT; Cheng MY; Tsai MH; Jou SB; Chang CW; Hsieh HY; Du X; Hellot S; McClung C; Hung C
Epilepsy Behav; 2020 Dec; 113():107464. PubMed ID: 33152580
[TBL] [Abstract][Full Text] [Related]
36. Comparative Validation of the S-STS, the ISST-Plus, and the C-SSRS for Assessing the Suicidal Thinking and Behavior FDA 2012 Suicidality Categories.
Sheehan DV; Alphs LD; Mao L; Li Q; May RS; Bruer EH; Mccullumsmith CB; Gray CR; Li X; Williamson DJ
Innov Clin Neurosci; 2014 Sep; 11(9-10):32-46. PubMed ID: 25520887
[TBL] [Abstract][Full Text] [Related]
37. What has been the impact of new drug treatments on epilepsy?
Chen Z; Brodie MJ; Kwan P
Curr Opin Neurol; 2020 Apr; 33(2):185-190. PubMed ID: 32049739
[TBL] [Abstract][Full Text] [Related]
38. Suicidal ideation and behavior screening in intractable focal epilepsy eligible for drug trials.
Hesdorffer DC; French JA; Posner K; DiVentura B; Pollard JR; Sperling MR; Harden CL; Krauss GL; Kanner AM
Epilepsia; 2013 May; 54(5):879-87. PubMed ID: 23448169
[TBL] [Abstract][Full Text] [Related]
39. Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants.
Posner K; Oquendo MA; Gould M; Stanley B; Davies M
Am J Psychiatry; 2007 Jul; 164(7):1035-43. PubMed ID: 17606655
[TBL] [Abstract][Full Text] [Related]
40. Third-Generation Antiseizure Medication in the Treatment of Benzodiazepine-Refractory Status Epilepticus in Poststroke Epilepsy: A Retrospective Observational Register-Based Study.
Winter Y; Sandner K; Vieth T; Gonzalez-Escamilla G; Stuckrad-Barre SV; Groppa S
CNS Drugs; 2023 Oct; 37(10):929-936. PubMed ID: 37784006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
